- Home
- VINC
VINC
Vincerx Pharma Inc.
as 04-01-2025 3:44pm EST
| Founded: | 2019 | Country: | United States |
| Employees: | N/A | City: | PALO ALTO |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | $40.00 | AVG Volume (30 days): | 1.4M |
| Analyst Decision: | Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -15.85 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.48 - $136.80 | Next Earning Date: | 05-13-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Vincerx Pharma Inc. News
VINC Breaking Stock News: Dive into VINC Ticker-Specific Updates for Smart Investing
MT Newswires
14 days ago
Vincerx Pharma Plans Reverse Merger With AI Infrastructure Firm QumulusAI
GlobeNewswire
14 days ago
Vincerx Pharma Announces Non-Binding Letter of Intent for Business Combination with QumulusAI
GlobeNewswire
a month ago
Vincerx Pharma Announces Termination of Reverse Merger Term Sheet and Evaluation of Strategic Alternatives
GlobeNewswire
2 months ago
Vincerx Pharma, Inc. and Oqory, Inc. Highlight Promising Data for Oqory’s TROP2 Antibody Drug Conjugate, OQY-3258
MT Newswires
2 months ago
Vincerx Pharma Files $100 Million Mixed Shelf
GlobeNewswire
2 months ago
Vincerx Pharma, Inc. Announces Reverse Stock Split
MT Newswires
3 months ago
Vincerx Pharma to Be Acquired by Oqory; Vincerx to Lose Jobs, Including Executives
GlobeNewswire
3 months ago
Vincerx Pharma Enters into a Binding Term Sheet for a Strategic Merger with Oqory, Inc.
Compare VINC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "VINC Vincerx Pharma Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.